SynthesisClinical pharmacology and therapeutics2020

Meta-Analyses of Clinical Efficacy of Risankizumab and Adalimumab in Chronic Plaque Psoriasis: Supporting Evidence of Risankizumab Superiority.

Han Witjes et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.